These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 378893)
21. Viral hepatitis in infancy and childhood. Mowat AP Clin Gastroenterol; 1980 Jan; 9(1):191-212. PubMed ID: 6994950 [No Abstract] [Full Text] [Related]
22. [Viral hepatitis and pregnancy]. Niesen M; Plotz EJ; Schneweis KE Gynakologe; 1982 Mar; 15(1):11-7. PubMed ID: 6804318 [No Abstract] [Full Text] [Related]
23. [Treatment of acute viral hepatitis in the light of current etiopathogenetic data]. Angelescu M Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1981; 33(3):193-206. PubMed ID: 6118920 [No Abstract] [Full Text] [Related]
25. Elimination of diseases from Europe through use of vaccines. Bytchenko BD; Dittmann S Dev Biol Stand; 1986; 65():3-11. PubMed ID: 3556775 [TBL] [Abstract][Full Text] [Related]
26. On the production and application of human and animal immunoglobulins in Bulgaria. Velev VK Prog Immunobiol Stand; 1970; 4():121-4. PubMed ID: 4098252 [No Abstract] [Full Text] [Related]
27. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. Zignol M; Peracchi M; Tridello G; Pillon M; Fregonese F; D'Elia R; Zanesco L; Cesaro S Cancer; 2004 Aug; 101(3):635-41. PubMed ID: 15274078 [TBL] [Abstract][Full Text] [Related]
28. [Results of a 25-year-long fight against infectious diseases in Slovakia. Analysis of the epidemiological situation in Slovakia during the past 25 years]. Cervenka J; Adamcová A Cesk Pediatr; 1977 May; 32(5):284-7. PubMed ID: 880684 [No Abstract] [Full Text] [Related]
29. [The social-economic significance of infectious diseases. I. Characteristics of the role of infectious morbidity during temporary disability]. Shakhanina IL; Argutina TP; Sumarokov AA Br J Soc Clin Psychol; 1970 Dec; 9(4):61-7. PubMed ID: 4250304 [No Abstract] [Full Text] [Related]
30. [Indications for the use of normal immunoglobulins and of specific immunoglobulins]. Winsnes R Tidsskr Nor Laegeforen; 1983 Jan; 103(3):222-4. PubMed ID: 6845325 [No Abstract] [Full Text] [Related]
31. Uses of immune globulins in the prophylaxis and treatment of viral infections. Weintrub PS Clin Lab Med; 1987 Dec; 7(4):897-910. PubMed ID: 2826075 [TBL] [Abstract][Full Text] [Related]
32. Immune globulin prophylaxis for viral hepatitis: to give or not to give. Sampliner RE Md State Med J; 1980 Apr; 29(4):43-5. PubMed ID: 7382564 [No Abstract] [Full Text] [Related]
33. [Effect of small doses of emetine in the therapy of virus diseases. New specific therapeutic method in viral hepatitis]. Fusillo A Minerva Med; 1973 Jan; 64(3):129-32. PubMed ID: 4686977 [No Abstract] [Full Text] [Related]
34. Vaccines and immunotherapies for the prevention of infectious diseases having cutaneous manifestations. Wu JJ; Huang DB; Pang KR; Tyring SK J Am Acad Dermatol; 2004 Apr; 50(4):495-528; quiz 529-32. PubMed ID: 15034501 [TBL] [Abstract][Full Text] [Related]
35. [Some acute infectious diseases in day care centers for children. 3. Infectious hepatitis, mumps]. Hahn M Z Arztl Fortbild (Jena); 1969 Mar; 63(5):293-5. PubMed ID: 4182127 [No Abstract] [Full Text] [Related]
36. Occurrence of antibodies precipitating human serum antigens in children in the course of infectious diseases. Kacprzak-Bergman I Arch Immunol Ther Exp (Warsz); 1975; 23(1):69-82. PubMed ID: 1115583 [No Abstract] [Full Text] [Related]
37. [Results of mass-longitudinal screening in Görlitz. 1. Morbidity of important infectious diseases]. Grzegorek R; Kirbis U; Richter J Arztl Jugendkd; 1977 Sep; 68(4):233-7. PubMed ID: 920530 [TBL] [Abstract][Full Text] [Related]